Earnings · China A-shares
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class A (688796) earnings
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class A published its Q3 report on 2026-10-29: net profit +173.77% year on year, +307.62% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -13.65% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +173.77%
- Excl. one-offs YoY
- +307.62%
- Net profit QoQ
- -47.94%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -6.32% | — |
| 3 days | -13.65% | — |
| 7 days | -4.57% | — |
| 14 days | -21.78% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 1 of 4 reports (average -0.88%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥312.45M | +173.77% | +307.62% | +49.09% | 0.70 | 13.38% | -13.65% | — | — |
| 2026 interim report | 2026-08-28 | ¥241.09M | +402.29% | +591.53% | +51.60% | 0.54 | 10.49% | -0.31% | -29.34% | -19.65% |
| 2026 Q1 report | 2026-04-28 | ¥104.03M | +885.41% | +789.46% | +73.68% | 0.23 | 4.67% | -2.39% | -11.44% | -10.82% |
| 2025 Q1 report | 2026-04-28 | -¥13.25M | — | — | — | -0.03 | -1.59% | -2.39% | -11.44% | -10.82% |
| 2025 annual report | 2026-03-27 | ¥173.20M | +416.37% | +405.39% | +40.63% | 0.43 | 16.85% | +12.85% | +18.31% | +6.46% |
| 2025 Q3 report | 2025-11-20 | ¥114.13M | +211.59% | +159.48% | +59.50% | 0.29 | 12.61% | — | — | — |
| 2025 interim report | 2025-09-17 | ¥48.00M | +194.72% | +151.54% | +51.27% | 0.12 | 5.56% | — | — | — |
| 2024 Q3 report | 2025-09-17 | -¥102.27M | — | — | — | -0.26 | -13.67% | — | — | — |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.